COVID-19 vaccine share of total mRNA revenues worldwide 2021-2035

Share of COVID-19 vaccine revenue of total forecasted mRNA product revenue worldwide from 2021 to 2035

Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035

Last update:

Sep 17, 2021

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2021 to 31/12/2035

In 2028, around 86 percent of all forecasted revenue of mRNA products is expected to be from COVID-19 vaccines. This statistic illustrates the share of COVID-19 vaccine revenue of total forecasted revenues from mRNA products worldwide from 2021 to 2035.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Share of COVID-19 vaccine revenue of total forecasted mRNA product revenue worldwide from 2021 to 2035

Get in touch with us for additional information

��ƽ��